Wednesday, October 30, 2013

Botox jab could ease arthritis and cancer without side effects: Single injection could offer pain relief for months

  • New molecule created by Sheffield University's Professor Bazbek Davletov 
  • Could provide pain-numbing effect of Botox without freezing the muscles
  • Created by fusing elements of Botox with those from the tetanus bug




  • A new drug created from Botox by a Sheffield University researcher could provide months of pain relief (file photo)
    A new drug created from Botox by a Sheffield University researcher could provide months of pain relief (file photo)

    Botox, best known for smoothing out wrinkles, could also help soothe the pain of cancer, arthritis and migraines – without any side effects. 
    Sufferers of chronic back pain and women who have given birth by Caesarean section could also benefit from the ‘super-Botox’ jab.
    A single injection could provide pain relief for months – removing the need for patients to take several daily doses of powerful tablets – and it could be injected into any part of the body. 
    Charities said the drug, invented by a researcher at Sheffield University, could revolutionise the treatment of pain.
    The main ingredient of the Botox used to prevent wrinkles is a bacterial poison known as botulinum.
    It works by preventing nerve cells from talking to muscles, which in turn stops muscles moving and wrinkles developing.
    It can also stop pain signals from being transmitted for months at a time. 
    However, fears that it will paralyse the area being treated have prevented it from being widely used for pain relief.
    To get round this, Sheffield University researcher Professor Bazbek Davletov took the pain-relieving part of Botox and ‘stapled’ it to a friendly part of a similar poison produced by the tetanus bug.
    The tetanus toxin ferries the pain-reliever to the spinal cord, where it stops pain signals being sent to the brain.
     

    The professor said: ‘In effect, we engineer pain relief by taking only good parts of toxic molecules.’ 
    Animal trials have had encouraging results and, if large-scale trials on people are successful, the drug could be on the market in as little as three years.
    Professor Davletov designed the drug while working at the MRC Laboratory of Molecular Biology in Cambridge.
    Painkiller: The new 'super-Botox' drug could help treat sufferers of chronic pain (file photo)
    Painkiller: The new 'super-Botox' drug could help treat sufferers of chronic pain (file photo)


    He said: ‘Currently painkillers relieve lingering pain only temporarily and often have unwanted side-effects. An injection of this new molecule at the site of pain could potentially relieve pain for many months.’ 
    And he added that a public which is willing to have injections for cosmetic purposes would not be squeamish about receiving medicine in the same way. 
    Migraine sufferers are likely to be the first to benefit. 
    Normal Botox can already be used as a treatment for crippling headaches, but fears that it will paralyse the face mean that many sufferers miss out. 

    'An injection of this new molecule at the site of pain could potentially relieve pain for many months'
    - Professor Bazbek Davletov, Sheffield University
    Cancer patients would also be high on the list as the side-effects of powerful painkillers such as morphine can be unbearable.
    Drugs widely used to ease the pain of arthritis can raise the risk of heart attacks and around one in five people who have a major operation are left in pain for several years.
    Professor Davletov, who reports his research in the journal Bioconjugate Chemistry, hopes the drug will cost around £1,000 a year, making it cheap enough for use on the NHS.
    Martin Ledwick, of Cancer Research UK, said: ‘Alongside developing new treatments for cancer, finding new and better ways of controlling pain is very important. 
    ‘If this new approach proves to be effective and have fewer side effects, it has the potential to be extremely useful to cancer patients and others with chronic pain.’ 
    Dr Fayyaz Ahmed, a neurologist, is a trustee for charity The Migraine Trust and chairman of the British Association for the Study of Headache.
    He said: ‘This sounds interesting and innovative, and if successful in what it is meant to achieve may revolutionise the way we currently treat pain and other neurological disorders.’ 
    Many A-list celebrities, including Nicole Kidman, Jennifer Aniston, Cindy Crawford and Dannii Minogue, have admitted having Botox in the past.


    Read more: http://www.dailymail.co.uk/news/article-2479300/Botox-jab-ease-arthritis-cancer-effects.html#ixzz2jE8QLD9R 
    Follow us: @MailOnline on Twitter | DailyMail on Facebook
     

    Tuesday, October 29, 2013

    Understanding your risk: Genetic testing for breast cancer

    Cyndi Pierre knew that her family history put her at increased risk of breast cancer. Both her mother and sister are survivors. So she did what she could to reduce her risk—she ate well, exercised, and got regular mammograms. She even got tested for the BRCA “breast cancer” gene mutations, which increase a woman’s risk of breast cancer exponentially—it was negative.

    “I thought I had covered all my bases, but I couldn’t shake this nagging feeling,” Pierre told FoxNews.com.

    Pierre, 45, from Rogers, Ark. wanted to have an MRI, but her insurance wouldn’t pay for it because her risk of breast cancer wasn’t high enough.

    Pierre’s nurse practitioner suggested a new genetic test, called BREVAGen, which analyzes seven genes that have been associated with breast cancer, but to a much smaller degree than the BRCA genes.

    BREVAGen showed Pierre’s lifetime risk of developing breast cancer was 33 percent—which may not sound high, but it’s nearly three times higher than the average woman’s. With those results, she sought approval from her health insurer to get a MRI, and found that she had early stage cancer.

    The new test combines a DNA sample, via a swab of your mouth, and a traditional assessment of personal and family risk factors. It may be most useful for women with known risk factors, such as a family history.

    The average woman has a 12 percent (or 1 in 8) risk of developing breast cancer if she lives to 95 years old. But women with a strong family history of breast cancer and other risk factors that increase her lifetime exposure to estrogen, may have a risk ranging from 10 percent to 30 percent or more over a lifetime, and current risk assessment models are not sensitive enough to pinpoint these risks.

    Having the BRCA gene mutations, as Angela Jolie famously revealed earlier this year increases the risk to between 60 and 90 percent! But researchers have found more subtle mutations, called SNPs, that increase your risk incrementally.

    In cancers that don’t have a strong BRCA mutation, it’s not a single mutation that leads to the disease but many individual SNPs, which contribute a small, but measurable risk. BREVAGen tests for seven SNPs.

    According to a study in Caucasian, postmenopausal women, BREVAGen reclassified 64 percent of women with intermediate risk. That means that 37 percent of women with intermediate risk were bumped down into a lower risk group, and 27 percent were bumped up into a higher risk group.

    “We’re trying to transition from a general impression of a woman’s risk to a factual one,” said Dr. Joel Evans, an OB-GYN and director of the Center for Women’s Health in Stamford, Conn.

    Knowing your individual risk could help you make decisions about screening and testing, and lower your anxiety if your risk was reduced by the test.

    “If we find out someone is at increased risk, we do increased surveillance, and depending on the risk, a woman might be a candidate for taking drugs that prevent breast cancer like tamoxifen,” said Evans, who receives speaking honorariums from Phenogen, which markets the test.

    But some experts warn that there’s no data showing that the test makes a difference in survival.

    “The study didn’t give women the test, follow them for many years, and see if their test predicted correctly, and how many times was it wrong,” said Dr. Debbie Saslow, director of Breast and Gynecologic Cancer at the American Cancer Society (ACS). “We don’t know how many times the test was wrong or how accurate it is. More data and research is needed.”

    In addition, because the test was validated in a study of Caucasian, postmenopausal women,  it’s not known whether the results can extend to others.

    Phenogen estimates that more than 3,000 women have been tested with BREVAGen in the U.S. The test itself costs $2,200 without insurance, and is covered by some insurance companies.

    For more information, visit BREVAGen.com.

    Laurie Tarkan is an award-winning health journalist whose work appears in the New York Times, among other national magazines and websites. She blogs about the Affordable Care Act for the WellBeeFile. Follow her on Twitter and Facebook.

    Could taking a vitamin D pill help ease the pain of an irritable bowel?

  • IBS is a collection of symptoms including abdominal pain and spasms
  • Up to a third of the population is thought to have IBS at some point
  • It's most prevalent in women between the ages of 19 and 32
  • Vicky had tried every drug, therapy and diet under the sun to cure her IBS
  • Nothing worked - until she tried vitamin D3 from fish oils





  • Life-changing: Taking vitamin D3 cured Vicky of her IBS symptoms
    Life-changing: Taking vitamin D3 cured Vicky of her IBS symptoms
    Vicky Grant was in a work meeting when once again she was gripped by painful stomach cramps.
    'I didn't know whether to make a dash to the bathroom or just sit it out and hope it would pass,' recalls Vicky, 43, a medical librarian, who is divorced and lives in Sheffield. 'I was coping with up to seven bouts of diarrhoea a day and it was really taking its toll on me.
    'I decided to risk it and stay put, but I was concentrating so hard on staying in control that everything being said in the meeting passed over my head.
    'I felt bloated, tired and fatigued. My weight was below 7st (I'm 5ft 3in). I'd lost so much weight and looked terrible - I'm sure people thought I had anorexia. It was also making me depressed.
    'I'd tried every drug, complementary therapy and diet under the sun, some things helped a little but nothing made my symptoms manageable. I was just so fed up with being ill all the time.'
    Vicky, then in her early 30s, had been struggling to cope with irritable bowel syndrome (IBS) since the age of 13. IBS is the medical name for a collection of symptoms including abdominal pain and spasms, diarrhoea, constipation or an erratic bowel, bloating, and wind.
    Up to a third of the population is thought to have IBS at some point, with one in ten experiencing symptoms so severe they seek medical help - IBS accounts for a tenth of all visits to GPs.
    But the condition is notoriously tricky to diagnose and treat: IBS doesn't show up on X-rays, blood tests or scans. Doctors still don't know what causes it, and unlike other bowel diseases it does not physically damage the gut, yet patients suffer very real symptoms.
     

    Treatment is often a case of trial and error - options include drugs for diarrhoea or constipation, antidepressants, relaxation and psychological therapies, and dietary changes.
    But could vitamin D offer another option? After years of debilitating symptoms and failed treatments, this is what helped Vicky, and her experience has now led to a major new study looking at the nutrient's benefits.
    Vicky first 'plucked up the courage' to see her GP in her early 20s. 'He told me I did have IBS and that in my case it was due to stress and advised me to tackle the stress,' she says.
    'I didn't think I was any more stressed than any of my friends and thought the stress I was under was at least partly due to coping with my IBS. I tried meditation, but it made no difference.
    'Over the years my IBS left me feeling totally drained.'
    IBS: A collection of symptoms including abdominal pain and spasms, diarrhoea, constipation and wind
    IBS: A collection of symptoms including abdominal pain and spasms, diarrhoea, constipation and wind
    Then, in her early 30s Vicky was finally referred to a gastroenterologist after she broke down in tears at her GP's because she felt so depressed. 'I felt I just couldn't cope with my symptoms any more.'
    The consultant she saw suggested antidepressants for her depression and anxiety and explained these can have a calming effect on the gut, too. 'I carried on trying alternative remedies - aloe vera juice, herbal supplements, counselling, hypnotherapy and probiotics to name but a few - but nothing fixed it,' she says. Vicky's experience is far from unusual, according to Dr Nick Read, chairman of the IBS Network's medical advisory group. 'Trying successive treatments is fairly typical as there isn't any one definitive treatment and it's a matter of deciding what makes most sense and works best for you.'  
    IBS is most common in women between the ages of 19 and 32.
    'It tends to occur in the more sensitive individuals, who can find themselves overwhelmed with their busy lives,' says Dr Read.
    'They tend to blame their diet, but symptoms of IBS often start or get worse after a significant change, such as a new job, a holiday, a breakdown of a relationship or the start of a new one, marriage, childbirth, or later, empty nesting, care for elderly parents, bereavement - the stuff of life,' he says, adding: 'Sometimes it follows an attack of food poisoning.'
    Such changes and stresses can make the bowel more sensitive to different foods, particularly fats and coffee as these cause the bowel to contract, and milk, wheat, and fruits and vegetables that cause gas. 'To understand IBS, think food and mood,' says Dr Read.
    Three years ago, Vicky took to the internet hoping to find a new treatment. She teaches medical students how to appraise medical journals and had read many papers in such publications about treatments for IBS, but says she 'also wanted to find out what patients were saying about what worked for them'.
    'One thing that kept cropping up online was how high-dose  vitamin D supplements could help,' recalls Vicky. 'I read one blog then reports from patients on forums talking about this - it was generating a lot of interest.'
    Female sufferers: IBS is most common in women between the ages of 19 and 32
    Female sufferers: IBS is most common in women between the ages of 19 and 32
    Vitamin D is a fat-soluble vitamin important for bone health, a healthy immune system, muscle growth and blood clotting. It is made by the body under the surface of the skin through exposure to sunlight. Small amounts are contained in dairy products, egg yolks, oily fish and fortified margarine.
    It's well known that people in the UK and other Northern countries have low levels of vitamin D in the winter months. Increasingly, research is linking a lack of vitamin D to a host of illnesses including inflammatory bowel disease, multiple sclerosis, colorectal cancer and depression.
    Based on what she'd read, Vicky started a low daily dose of the nutrient (1,000 international units) - she took vitamin D2, a form which comes mainly from plants. But it had no effect.
    'Then a work colleague who has multiple sclerosis mentioned that vitamin D3 from fish oils is closer to the type the body makes naturally and was more effective and should be taken at a higher dose,' says Vicky. 'So I switched to 4,000 international units a day of D3, which is a safe dose. Within days, my symptoms eased and progressively improved over the months.
    'After years of symptoms, my diarrhoea, cramps, pain and bloating disappeared. I started to feel well, put on weight and my depression lifted.
    'It was amazing. My symptoms would flare up again though, if I forgot to take it.'
    With the help of medical researchers she knew from her work at Sheffield University medical school, Vicky wrote up her experience as a case report for the British Medical Journal - she included anecdotal reports on vitamin D from blogs, which suggested it worked in 70 per cent of cases.
    The article generated a lot of interest. 'Lots of patients wanted to know more but I knew doctors wouldn't - quite rightly - recommend vitamin D unless it was backed up by clinical trial evidence,' says Vicky, who is now studying for a doctorate based on patient experiences of IBS.
    Now the university's oncology department is to run a randomised controlled trial of the treatment involving 100 IBS patients - half will take a high daily dose (3,000 international units) of vitamin D3, the other half a placebo, for three months.
    A possible cure for the symptoms of IBS? Vitamin D3 (from fish oils) is effective
    A possible cure for the symptoms of IBS? Vitamin D3 (from fish oils) is effective
    'Hopefully this will produce some hard evidence one way or the other,' says Vicky, who is a researcher on the trial (which will soon be recruiting patients).
    There's been an 'explosion' of research into the role of vitamin D in illnesses including cancer multiple sclerosis and inflammatory bowel disease, says Dr Bernard Corfe, head of Sheffield University's molecular gastroenterology research group. 'So it is not unreasonable to investigate whether it plays a role in IBS,' he adds.
    There are several ways vitamin D might work, including boosting the immune system and improving the gut's barrier. Dr Read says there is evidence some types of IBS involve a low level of inflammation in nerve endings in the gut.
    'Inflammation around the gut's nerve cells may make the intestine more sensitive to food and stress,' he explains. 'We can't say vitamin D works as a treatment for IBS yet. Only a properly designed trial will establish whether it works or not.'
    Julian Walters, professor of gastroenterology at Imperial College, London, agrees the idea that vitamin D may play a role in IBS is 'plausible'.
    'We shouldn't assume it will work,' he cautions. 'It could just be the power of placebo.'


    Read more: http://www.dailymail.co.uk/health/article-2478549/Could-taking-vitamin-D-pill-help-ease-pain-irritable-bowel.html#ixzz2jAOmLcDx 
    Follow us: @MailOnline on Twitter | DailyMail on Facebook
     

    The new type of antidepressant that could work in just DAYS rather than weeks or months

  • Research shows blocking a hormone receptor in brain induces fast-acting antidepressant effects in mice - it could lead to new drugs for humans
  • Selectively blocking these serotonin receptors significantly reduced depression-like behaviour in mice in just five days
  • Currently, only two drugs - ketamine and scopolamine - act rapidly. But due to severe side effects, neither is suitable for human use



  • A fast-acting antidepressant pill which could alleviate symptoms of depression within days is being developed.
    Medicines used currently can take weeks - and for some patients, months - before they begin to alleviate the symptoms of depression. 
    Now, scientists in the U.S. have discovered that blocking a hormone receptor in the brain induces fast-acting antidepressant effects in mice, indicating a potential new class of treatments for depression. 
    A fast-acting antidepressant treatment which could alleviate symptoms of depression within five days is being developed
    A fast-acting antidepressant treatment which could alleviate symptoms of depression within five days is being developed by scientists in the U.S.

    The study's senior author Dr Stephanie Dulawa, associate professor of psychiatry and behavioural neuroscience at the University of Chicago, said: ‘One of the biggest problems in the treatment of depression today is a delay in onset of therapeutic effects. 
    ‘There has been a great need to discover faster-acting drugs.’
    Dr Dulawa said the delayed onset of antidepressant medicines’ benefits can significantly impact patients, especially those with severe depression, who often spend months switching between ineffective medications.
     

    Currently, only two drugs - ketamine and scopolamine - act rapidly. However, due to severe side effects, neither is suitable for human use.
    In looking for a new class of fast-acting drug, Dr Dulawa and her team tested biological pathways that had previously been shown to have antidepressant effects but had never been studied for rate of onset. 
    They looked at different serotonin receptors – serotonin is a neurotransmitter that has been shown to regulate mood, memory and appetite.
    Medicines used currently can take weeks - and for some patients, months - before they begin to alleviate the symptoms of depression
    Medicines used currently can take weeks - and for some patients, months - before they begin to alleviate the symptoms of depression

    Of these subtypes, serotonin 2C receptors stood out. Selectively blocking these receptors in mice significantly reduced depression-like behaviour in just five days, compared to a minimum of two weeks for conventional antidepressant medication.
    The paper's lead author Mark Opal, a graduate student at the University of Chicago, said: ‘We observed fast-acting therapeutic effects in multiple behavioural tasks after we administered compounds that selectively block serotonin 2C receptors.
    ‘We began our measurements at five days, but we think there's a possibility it could be effective even sooner than that.’
    Dr Dulawa said serotonin 2C receptors normally inhibit the release of dopamine, another neurotransmitter commonly associated with mood, from certain neurons in the brain. 
    The researchers believe that when 2C is blocked, more dopamine is released into some regions of the brain. The team also observed a rise in the levels of biomarkers that indicate antidepressant effects are occurring.
    Dr Dulawa said the findings, published in the journal Molecular Psychiatry, are the first new biological mechanism that has shown the ability to rapidly alleviate symptoms of depression since ketamine and scopolamine, and it potentially represents a much safer alternative. 
    Some current antidepressants on the market already affect serotonin 2C receptors, although not selectively, and Dr Dulawa believes they are likely to be safe for human use. 
    The team is now investigating compounds suitable for clinical trials.
    Dr Dulawa said: ‘One of the primary advantages to our discovery is that this is much more of an innocuous target than others that have been identified.’


    Read more: http://www.dailymail.co.uk/health/article-2478789/The-new-antidepressant-work-just-DAYS.html#ixzz2jAMOFQdt 
    Follow us: @MailOnline on Twitter | DailyMail on Facebook
     

    Monday, October 28, 2013

    Kids should spend no more than TWO HOURS online per day, warn doctors - but will parents have any hope of enforcing that rule?

  • Many parents are clueless' about the impact media exposure can have on their children, says Dr. Victor Strasburger, lead author of a new American Academy of Pediatrics policy
  • Under the new policy, those two hours include using the internet for entertainment, including Facebook, Twitter, TV and movies; online homework is an exception




  • Doctors 2 parents: Limit kids' tweeting, texting & keep smartphones, laptops out of bedrooms. #goodluckwiththat.
    The recommendations are bound to prompt eye-rolling and LOLs from many teens but an influential pediatricians group says parents need to know that unrestricted media use can have serious consequences.
    It's been linked with violence, cyberbullying, school woes, obesity, lack of sleep and a host of other problems. It's not a major cause of these troubles, but 'many parents are clueless' about the profound impact media exposure can have on their children, said Dr. Victor Strasburger, lead author of the new American Academy of Pediatrics policy.
    Scroll down for video
    Two-hour limit: An influential pediatricians group says parents need to know that unrestricted media use can have serious consequences for kids and teens aged between eight and 18
    Two-hour limit: An influential pediatricians group says parents need to know that unrestricted media use can have serious consequences for kids and teens aged between eight and 18


    'This is the 21st century and they need to get with it,' said Strasburger, a University of New Mexico adolescent medicine specialist.
    The policy is aimed at all kids, including those who use smartphones, computers and other internet-connected devices. It expands the academy's longstanding recommendations on banning televisions from children's and teens' bedrooms and limiting entertainment screen time to no more than two hours daily.
    Under the new policy, those two hours include using the internet for entertainment, including Facebook, Twitter, TV and movies; online homework is an exception.

     

    The policy statement cites a 2010 report that found U.S. children aged 8 to 18 spend an average of more than seven hours daily using some kind of entertainment media. Many kids now watch TV online and many send text messages from their bedrooms after 'lights out,' including sexually explicit images by cellphone or internet, yet few parents set rules about media use, the policy says.
    'I guarantee you that if you have a 14-year-old boy and he has an internet connection in his bedroom, he is looking at pornography,' Strasburger said.
    The policy notes that three-quarters of kids aged 12 to 17 own cellphones; nearly all teens send text messages, and many younger kids have phones giving them online access.
    'I guarantee you that if you have a 14-year-old boy and he has internet in his bedroom, he is looking at pornography'
    'Young people now spend more time with media than they do in school — it is the leading activity for children and teenagers other than sleeping' the policy says.
    Mark Risinger, 16, of Glenview, Ill., is allowed to use his smartphone and laptop in his room, and says he spends about four hours daily on the internet doing homework, using Facebook and YouTube and watching movies.
    He said a two-hour internet time limit 'would be catastrophic' and that kids won't follow the advice, 'they'll just find a way to get around it.'
    Strasburger said he realizes many kids will scoff at advice from pediatricians — or any adults.
    'After all, they're the experts! We're media-Neanderthals to them,' he said. But he said he hopes it will lead to more limits from parents and schools, and more government research on the effects of media.
    The policy was published online Monday in the journal Pediatrics. It comes two weeks after police arrested two Florida girls accused of bullying a classmate who committed suicide. Police say one of the girls recently boasted online about the bullying and the local sheriff questioned why the suspects' parents hadn't restricted their internet use.
    Mark's mom, Amy Risinger, said she agrees with restricting kids' time on social media but that deciding on other media limits should be up to parents.
    'I think some children have a greater maturity level and you don't need to be quite as strict with them,' said Risinger, who runs a communications consulting firm.
    Her 12-year-old has sneaked a laptop into bed a few times and ended up groggy in the morning, 'so that's why the rules are now in place, that that device needs to be in mom and dad's room before he goes to bed.'
    Sara Gorr, a San Francisco sales director and mother of girls, ages 13 and 15, said she welcomes the academy's recommendations.
    Her girls weren't allowed to watch the family's lone TV until a few years ago. The younger one has a tablet, and the older one has a computer and smartphone, and they're told not to use them after 9pm.
    'There needs to be more awareness,' Gorr said. 'Kids are getting way too much computer time. It's bad for their socialization, it's overstimulating, it's numbing them.'


    Read more: http://www.dailymail.co.uk/femail/article-2478415/Kids-spend-TWO-HOURS-online-day-warn-doctors--parents-hope-enforcing-rule.html#ixzz2j3OeAOCY 
    Follow us: @MailOnline on Twitter | DailyMail on Facebook